Amerise Biosciences vs Coca-Cola: Fair Value & Quality
Both stocks run through our valuation models. Here is how Amerise Biosciences (AMERISE) and Coca-Cola (KO) compare, as of Aug 19, 2026.
As of Aug 19, 2026, Fair Value Calculator sees Coca-Cola as the less overvalued of the two: Amerise Biosciences trades at ₹0.85 versus a fair value of ₹0.32 (-62%), while Coca-Cola trades at $88.82 versus $36.57 (-59%).
Amerise Biosciences
AMERISE.BSE · INR · Financial Services
-62%
upside to fair value
overvalued
Price₹0.85
Fair Value₹0.32
Quality65/100
Coca-Cola
KO · USD · Consumer Staples
-59%
upside to fair value
overvalued
Price$88.82
Fair Value$36.57
Quality67/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Amerise BiosciencesCoca-Cola
Valuation
—P/E (TTM)25.6×
0.02×P/S (TTM)7.12×
—P/B10.91×
—EV/EBITDA22.9×
—PEG4.15×
—Dividend yield2.4%
—Dividend per share$2.06
Profitability
0%Net margin28%
77%Operating margin35%
0%Return on equity43%
0%Return on assets10%
Growth
-58%Revenue growth (YoY)12%
—Avg. growth/yr (3Y)3.7%
—Avg. growth/yr (5Y)7.7%
Balance & size
—Debt / equity1.31×
$0MMarket cap$351B
weakGrowth qualitymixed
Coca-Cola leads: 2 to 4 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Amerise Biosciencesof which business quality 64 · market factors 57Coca-Colaof which business quality 62 · market factors 76
ProfitabilityMargins and returns on capital today
10
71
Quality GrowthAre margins and returns improving?
51
59
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
76
72
Low VolatilityCalm price path (market factor)
50
96
MomentumPrice trend over the last 3–12 months (market factor)
59
58
52W MomentumDistance to the 52-week high (market factor)
61
84
Net IssuanceBuybacks instead of dilution
82
84
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Amerise Biosciences
Earnings-Based₹0.28
Multiples₹0.37
Asset-Based₹5.47
Economic Profit₹4.29
4 of 6 models see the stock below the current price.
Coca-Cola
DCF Models$28.16
Earnings-Based$22.41
Dividend Discount$31.26
Multiples$39.24
Asset-Based$5.01
Growth DCF$11.71
Economic Profit$24.81
Growth Earnings$51.37
25 of 25 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Amerise Biosciences
Bear ₹0.24Fair Value ₹0.32Bull ₹0.40
₹0.85 = current price (white tick)
Coca-Cola
Bear $21.38Fair Value $36.57Bull $47.76
$88.82 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Amerise Biosciences · Financial Services
Quality score65 · Top 25%
Fair value upside-62% · below median
Coca-Cola · Consumer Staples
Quality score67 · Top 25%
Fair value upside-59% · bottom 25%
Bottom line
As of Aug 19, 2026, Fair Value Calculator sees Coca-Cola as the less overvalued of the two: Amerise Biosciences trades at ₹0.85 versus a fair value of ₹0.32 (-62%), while Coca-Cola trades at $88.82 versus $36.57 (-59%).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
